Loading stock…

Glaukos Corporation (GKOS) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Glaukos Corporation

GKOSMarket cap $9.53BPrice $161.6

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Equipment

Makes tiny implants and devices that treat glaucoma and corneal disease, pioneering micro-invasive surgery that's replaced riskier traditional procedures. Its iStent was the first implant of its kind ever approved by the FDA, redefining eye surgery.

In Bastion Portfolios?

52W Return+85%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+22%9

Revenue Forecast

Rev CAGR (1y)+36%9

Rev CAGR (3y)+29%10

Rev CAGR (5y)+23%10

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+20%5

EPS Growth Y+3+243%10

Quality

Margins

EBIT Margin-13%1

Net Income Margin-31%1

Free Cash Flow Margin-2%2

Debt

Net Debt/EBITDAna–

Efficiency

ROE-26%1

ROA-20%1

Earnings Stabilityna–

GEAR+WEAK19

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)1,2691

P/E Ratio (Forward 3y)961

P/BV14.01

EV Multiples

EV/EBITDA Fwd2,5651

EV/EBIT Fwdna–

Yield

Free Cash Flow Yield-0.1%3

Dividend Yieldna–

Momentum

Short term

1 month return-9%3

3 month return+7%8

YTD return+43%9

Mid term

Price vs 52wHigh84%6

1 year return+92%10

Long term

3 year return+124%8

5 year return+252%9

Risk Shield

Price Risk

Beta1.04

Volatility51%3

Free Cash Flow

Free Cash Flow Margin-2%2

Free Cash Flow Yield-0.1%3

Quality

ROCE-9%1

Earnings Stabilityna–

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

GKOSGlaukos

Revenue FY25$383M

GROWTH RATING↗

VERY STRONG94 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+22%9

Revenue, next 1Y+36%9

Revenue, next 3Y, CAGR+29%10

Revenue, next 5Y, CAGR+23%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+243%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 94% of companies worldwide.

Revenue grew 22%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 29%/yr over the next 3 years, ahead of most of the market.10/10

Revenue grew 22%/yr over the last 3 years and is set to grow 29%/yr from here.

The runway holds up: revenue is set to grow 23%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG77 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return+7%8

YTD return+43%9

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+92%10

3-year return+124%8

5-year return+252%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +124% over three years and +252% over five, ahead of 80% of the market.

It's up 92% over the past year, but 16% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+7%) and so far this year (+43%).

WATCH

None flagged.

WEAKNESSES

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally. The market is behind it — a core fit for momentum strategies. The one thing to watch: the stock is underperforming over the past month.

04Value

Are you paying a fair price for it?

Stop guessing on Glaukos Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

GKOSGlaukos

Revenue FY25$383M

GROWTH RATING↗

VERY STRONG94 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+22%9

Revenue, next 1Y+36%9

Revenue, next 3Y, CAGR+29%10

Revenue, next 5Y, CAGR+23%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+243%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 94% of companies worldwide.

Revenue grew 22%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 29%/yr over the next 3 years, ahead of most of the market.10/10

Revenue grew 22%/yr over the last 3 years and is set to grow 29%/yr from here.

The runway holds up: revenue is set to grow 23%/yr over five years.10/10

WATCH

None flagged.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that's speeding up. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG77 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return+7%8

YTD return+43%9

MID & LONG-TERM▾SCORE

% of 52-week high84%6

1-year return+92%10

3-year return+124%8

5-year return+252%9

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +124% over three years and +252% over five, ahead of 80% of the market.

It's up 92% over the past year, but 16% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over three months (+7%) and so far this year (+43%).

WATCH

None flagged.

WEAKNESSES

The stock is underperforming over the past month (-9%).

BOTTOM LINE

Momentum Leader

04Value

Are you paying a fair price for it?

Stop guessing on Glaukos Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community